BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26402985)

  • 1. An insight into statin use and its association with muscular side effects in clinical practice.
    Farcas A; Bucsa C; Leucuta D; Mogosan C; Bojita M; Dumitrascu D
    Rom J Intern Med; 2015; 53(2):153-60. PubMed ID: 26402985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-induced muscular side effects at rest and exercise - An anatomical mapping.
    Berent T; Berent R; Steiner S; Sinzinger H
    Atheroscler Suppl; 2019 Dec; 40():73-78. PubMed ID: 31447216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
    Nichols GA; Koro CE
    Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-drug Interactions of Statins Potentially Leading to Muscle-Related Side Effects in Hospitalized Patients.
    Bucsa C; Farcas A; Leucuta D; Mogosan C; Bojita M; Dumitrascu DL
    Rom J Intern Med; 2015; 53(4):329-35. PubMed ID: 26939209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-induced muscular symptoms: a report of 3 cases.
    Kumar AJ; Wong SK; Andrew G
    Acta Orthop Belg; 2008 Aug; 74(4):569-72. PubMed ID: 18811049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle symptoms associated with statins: a series of twenty patients.
    Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
    Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
    Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing statin-induced muscle toxicity in a lipid clinic.
    Blaier O; Lishner M; Elis A
    J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
    Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.
    Bruckert E; Hayem G; Dejager S; Yau C; Bégaud B
    Cardiovasc Drugs Ther; 2005 Dec; 19(6):403-14. PubMed ID: 16453090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative chronic use of statins and the risk of muscle complaints in patients undergoing knee and hip endoprosthesis surgery.
    Laisalmi-Kokki M; Tolonen K; Miettinen H; Kokki H
    J Clin Anesth; 2010 Mar; 22(2):81-7. PubMed ID: 20304347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin Associated Muscular Adverse Effects.
    Kammoun R; Charfi O; Lakhoua G; Zaiem A; Daghfous R; Kastalli S; Aouinti I; Aidli SE
    Curr Drug Saf; 2024; 19(1):114-116. PubMed ID: 36847228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.